Literature DB >> 9361905

Characterization and modulation of immune stimulation by modified oligonucleotides.

R T Boggs1, K McGraw, T Condon, S Flournoy, P Villiet, C F Bennett, B P Monia.   

Abstract

Single-stranded oligodeoxynucleotides (ODNs) were tested for their ability to stimulate NK cells isolated from murine spleens to lyse target cells. Various sequences were evaluated, some of which have been shown previously to exhibit pharmacologic activity in murine model systems. It was confirmed that the CpG motif was stimulatory only in specific sequence contexts, and we found that phosphorothioate backbones were, in general, less stimulatory than phosphodiester backbones. In addition, this stimulation could be reduced by methylating the cytosine of the CpG and eliminated by modifying all of the cytosines contained in an ODN with methyl, bromo, or iodo modifications to the 5 position of the cytosine ring. These results were compared with the ability of a subset of these ODN sequences to stimulate B cell proliferation in vitro. In this comparison, phosphorothioate backbones were found to be required, and the context of the CpG motif was found to be less critical for activation. Finally, one of the most potent ODNs was shown to activate NK and B lymphocytes when administered in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361905     DOI: 10.1089/oli.1.1997.7.461

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  7 in total

Review 1.  Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.

Authors:  S Yamamoto; T Yamamoto; S Iho; T Tokunaga
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.

Authors:  Abbi L Engel; Gregory E Holt; Hailing Lu
Journal:  Expert Rev Clin Pharmacol       Date:  2011-03       Impact factor: 5.045

3.  In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model.

Authors:  Christina C N Wu; Mojgan Sabet; Tomoko Hayashi; Rommel Tawatao; Joshua Fierer; Dennis A Carson; Donald G Guiney; Maripat Corr
Journal:  Cell Immunol       Date:  2008-05-20       Impact factor: 4.868

4.  Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1.

Authors:  Jessica L Childs-Disney; Raman Parkesh; Masayuki Nakamori; Charles A Thornton; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2012-11-07       Impact factor: 5.100

5.  Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.

Authors:  Tuan Tran; Jessica L Childs-Disney; Biao Liu; Lirui Guan; Suzanne Rzuczek; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2014-02-19       Impact factor: 5.100

Review 6.  RNAi therapeutics: a potential new class of pharmaceutical drugs.

Authors:  David Bumcrot; Muthiah Manoharan; Victor Koteliansky; Dinah W Y Sah
Journal:  Nat Chem Biol       Date:  2006-12       Impact factor: 15.040

7.  Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant.

Authors:  H Zhang; R Hanecak; V Brown-Driver; R Azad; B Conklin; M C Fox; K P Anderson
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.